About
A Chinese peptide manufacturer global buyers can audit.
Founded 2013 in Shanghai, China, PeptideXpo manufactures, documents, and ships research and cosmetic peptides under one quality system. Our buyers are compounding pharmacies, med-aesthetic brands, research labs, and distributors across 30+ countries.
Our Facility
See the line we ship from.
The video below is a 30-second walk-through of our active vial-filling line in Shanghai — same line every order ships from. No stock footage.
PeptideXpo · Vial-filling line, Shanghai · 30s walk-through
Filling line · 30s walk-through
Lyophilizer · 15s
Tap to play with sound · loops muted by default
Manufacturing & Capacity
Real lines. Real capacity. Not a trading desk.
PeptideXpo operates dedicated vial-filling and lyophilization lines under ISO 7/8 cleanroom conditions — standardized at 10 vials per box, fully customizable on request.
2 lines
Vial filling + Lyophilization, independently qualified.
ISO 7 / 8
Cleanroom grades for filling and packaging.
0.5 – 100 kg
From pilot scale to bulk production.
10 vial / box
Custom packaging on request.
Leadership
A small team of senior operators.
We deliberately keep our team senior. Every buyer-facing role has 10+ years in pharmaceutical or peptide manufacturing — including the people who answer your inquiry.
Head of Manufacturing
20+ years in peptide API production
Oversees vial filling & lyophilization lines, batch records, and capacity planning.
Head of Quality Assurance
Pharmaceutical chemist, USP <1225>-aligned
Owns analytical methods, stability program, and COA approval workflow.
Head of R&D
Custom synthesis & OEM lead
Sequence design, modifications (PEG, Cu, acetyl), pilot scale-up.
Head of Global Sales
B2B medical and aesthetic markets
Direct contact for compounding pharmacies, med spa brands, and distributors.
Timeline
A decade of capability build-out.
2013
Founded in Shanghai. Initial focus: research peptides for academic and CRO clients.
2016
Vial-filling line commissioned. Standard 10-vial packaging adopted.
2018
Lyophilization line online. Expanded into cosmetic peptides.
2020
First GLP-1 family API shipments to compounding pharmacy clients in North America.
2022
FDA DMF filed. Third-party stability program established.
2024
Capacity expansion: 0.5–100 kg batch flexibility, ISO Class 7 cleanroom upgrade.
2026
30+ countries served. 90+ SKU catalog. Active in FDA PCAC regulatory dialogue.
Let's talk peptides.
First response under 12 hours · Catalog · Sample COA · MOQ · Lead time. Our regulatory and sales teams review every inquiry before pricing.